
Clobetasol: The strongest class of topical steroid. It clears thick, stubborn plaques quickly, and it comes with firm limits on how much, how long and where. Humira: An injected biologic for moderate to severe plaque psoriasis. It blocks TNF, one of the main inflammation signals behind psoriasis, and is usually given as a shot under the skin every other week.


Choose for a short, strong course to clear thick, stubborn plaques on the body or scalp — with firm limits on amount and time.
Choose for moderate to severe psoriasis or hidradenitis suppurativa — the first approved biologic for HS, now with cheaper biosimilars.
Can you take them together?
Clobetasol is often used on remaining stubborn patches while on Humira. It does not interact with the biologic.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Activates steroid receptors: Binds receptors inside skin and immune cells. Turns down inflammatory signals: Changes gene activity to reduce inflammatory messengers. Eases redness and itch: Swelling and irritation settle as inflammation falls.
Simplified glucocorticoid receptor-mediated effects in steroid-responsive skin inflammation. Full effects also involve other pathways. No claim of antimicrobial action or cure; formulation and potency affect clinical use.

Binds TNF: Captures an immune messenger that promotes inflammation. Reduces inflammatory signaling: TNF has less ability to activate its receptors. Lets inflamed skin settle: Conditions such as psoriasis can improve over time.
Adalimumab binds TNF-alpha and inhibits its interaction with p55/p75 TNF receptors. This image focuses on skin inflammation; Humira also has other indications.
When to Apply: Twice a day, on the affected plaques only, in the thinnest film that covers them. One fingertip unit, the amount along the last joint of an adult index finger, covers about two adult palms. Most labels cap use at 50 grams a week. Do not cover it with plastic wrap or a tight dressing unless told to.
How to Start: Twice daily for two weeks, then stop and be reviewed. Some scalp products allow up to four weeks. Keep it off the face, eyelids, armpits and groin unless a clinician prescribed it for that site with a set duration, as in lichen sclerosus.
If It Irritates: Burning and stinging are likelier from alcohol-containing solutions, foams and gels on broken skin; the ointment settles it. Redness or itch that worsens over a week or two can be an allergy to the steroid or a preservative, and needs a different drug.
If It Is Not Working: Two weeks of correct twice-daily use is a proper test. Extending it is the wrong move. Reassess the diagnosis, check for infection, and ask about a different class — clobetasol is already the top of the ladder.
Adults are not dosed by body weight. You start with a larger loading dose to get levels up fast, then settle into an every-other-week rhythm.
Starting dose: 80 mg on day one, as one 80 mg injection or two 40 mg injections at different spots.
One week later: 40 mg.
Usual dose: 40 mg every other week, the same day of the week each time.
If it stops working: Some people move to weekly injections, others switch drugs. The prescriber's call.
Other conditions: Hidradenitis suppurativa uses a heavier loading dose and weekly maintenance, so do not assume a friend's schedule matches yours.
How long: Long term, with no set course length. It continues while it works and is tolerated.
For a standard two-week course on a limited area in a healthy adult, monitoring is a skin check, not a blood test. Did the plaque clear? Has the skin thinned, or have stretch marks or fine blood vessels appeared?
On large areas, under dressings, in repeated courses or in children, the concern is your own cortisol production, and a doctor may test for adrenal suppression. Prescribers also watch how many tubes get dispensed per month.
Clobetasol is not a drug to stay on. Conditions that keep needing it get switched to a weaker steroid, a vitamin D analog, a calcineurin inhibitor or a systemic treatment for maintenance, with clobetasol kept for flares. Around the eyes, prolonged use raises the risk of glaucoma and cataract, another reason eyelid use is not casual.
Everyone is screened for tuberculosis before the first dose — a skin test or TB blood test, often with a chest X-ray. TNF blockers can wake a dormant TB infection, so a positive screen is treated first and adalimumab waits until that treatment is under way. Testing is often repeated yearly, or sooner if you live somewhere TB is common.
Hepatitis B and C are checked too, because hepatitis B can reactivate when the immune signal is blocked.
After that there is no fixed blood test schedule like methotrexate's. Many doctors check a blood count and liver tests occasionally. Most monitoring is clinical — how the skin looks, and whether you are getting more infections than usual.
Skin should be checked periodically, because TNF blockers are linked to a small increase in skin cancer. The label also carries a boxed warning about serious infections and about lymphoma and other cancers, based mostly on rare cases in children and young adults. The absolute risk is low, but it is why this prescription gets regular review.
Any time of day, but pick a set day of the week and keep to it. Every other week is easy to lose track of, so set a phone reminder on day one.
Take the pen or syringe out of the fridge 15 to 30 minutes before injecting. Cold liquid stings more. Do not warm it in the microwave or hot water.
Inject into the front of the thigh or the belly, at least two inches from the navel. Rotate the spot each time, and avoid skin that is bruised, red, hard, tender or scarred. Never inject through a plaque. A nurse or pharmacist should train you in person for the first dose. Used pens go in a sharps container, never the household bin.
Inject as soon as you remember, then return to your original schedule rather than shifting future doses. Never inject two doses to catch up. If you have missed more than one dose, call the prescriber before restarting — long gaps can blunt how well it works.
Approximate windows, not promises.
First few minutesApplying it: A thin layer on the plaque only. Most courses run two weeks.
First few minutesThe injection: A sting for a few seconds. Injection site reactions, if they happen, show up in the first weeks.
Days 1 to 3Itch first: Itching and soreness ease quickly, often before the plaque looks different. After months of itch, that is what people notice.
Days 3 to 10Flattening: Scale lifts, thickness drops, redness fades. This is the stage it is prescribed for.
Weeks 1 to 2Judge it here: Clearance is common by two weeks on limbs. Severe eczema flares settle in the same window, as a short rescue, not ongoing treatment.
Weeks 2 to 4Palms and soles: Thick skin absorbs poorly, so results take longer even with a class 1 steroid.
Weeks 4 to 12Lichen sclerosus: The genital skin exception, and one of the few longer courses. Supervised, it reduces itch and helps prevent scarring.
Weeks 4 to 12Working: Plaques flatten, scale lifts and redness fades from the middle outward. Most of the visible change happens here. Psoriatic arthritis improves on a similar timeline, and hidradenitis suppurativa settles to fewer painful lumps on its own heavier schedule.
Weeks 6 to 12Scalp alopecia areata and discoid lupus: Slower, less predictable, usually part of a wider plan.
After stoppingHolding: Plaques often return within weeks unless something gentler takes over. Brown or gray patches left behind are pigment change and fade over months.
Weeks 1 to 4Starting: Itching often eases before the plaques look different, and some people see the scale thin early.
Week 16Judge it here: The point the trials measured. Most people reached at least a 75 percent improvement in skin involvement and severity, and a smaller share cleared almost completely.
Months 6 to 12Nails: The slowest, because a nail takes months to grow out. Pitting and lifting improve well after the skin has settled.
After the first yearLong term: Most people who respond keep responding.
Sorted by what to do about them.
Generic clobetasol cream, ointment and solution are cheap and usually covered. Branded foams, sprays and shampoos cost many times more than the equivalent tube, and plans often want a generic first.
The weekly limit caps how much you use anyway, so tube size matters less here than with milder steroids. If a branded form is unaffordable, the generic cream or ointment is the same drug at the same strength.
The list price is very high, tens of thousands of dollars a year. Almost nobody pays that. What you pay depends on your insurance, and getting there takes paperwork.
Prior authorization is close to universal. Most plans require you to have tried and failed something cheaper first — phototherapy, methotrexate or another systemic drug — and they want records to prove it.
Biosimilars changed the picture. Several have been sold in the United States since 2023, some at much lower list prices. Which one you get is usually decided by your plan's formulary, not your dermatologist, and plans switch year to year. A switch is a paperwork event, not a medical downgrade, though you may need retraining on a different pen.
Manufacturer copay cards can bring the cost down to very little with commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or with no insurance, manufacturer and foundation assistance programs are the usual route, and their rules change often.
Clobetasol is in the strongest class, hydrocortisone the weakest — hundreds of times apart. That is why the percentages on the tubes tell you nothing.
That is where the evidence sits. Studies show suppression of your own cortisol production after about two weeks of full use, and thinning builds with continuous use. Labels also cap use at 50 grams a week.
Not unless a clinician prescribed it for the face with a set duration. Facial and eyelid skin absorb far more and thin fastest, and long use near the eyes raises glaucoma and cataract risk.
Often, and sometimes more inflamed than before. That rebound is expected, which is why a short course is paired with something gentler to hold the result.
It can. Pale patches show more on deeper skin tones and usually recover slowly after stopping. Untreated inflammation leaves light and dark marks too, so skipping treatment is not a way around it.
Deliberately, in lichen sclerosus, where treatment helps prevent permanent scarring, under supervision with a defined plan. Different from a leftover tube on an undiagnosed groin rash, where it causes thinning and stretch marks fast.
A large protein grown in living cells rather than a factory chemical. That is why it is injected, and why it lives in the fridge.
A sharp sting for a few seconds. Letting it warm to room temperature first makes a real difference, and citrate-free versions sting less than the original.
Some change by 4 weeks, and about 16 weeks before you judge it fairly. If nothing has happened by then, talk about switching.
Yes, apart from live ones. The flu shot, COVID, pneumonia vaccines and Shingrix are fine and usually recommended. Have live vaccines before you start.
A simple cold is usually not a reason to skip a dose. Anything with a fever, or needing antibiotics, should be checked with the prescriber first.
It must be shown to have no clinically meaningful difference from the original. The pen changes; what is inside does the same job.